Lu, Enzhou,
Gareev, Ilgiz,
Yuan, Chao,
Liang, Yanchao,
Sun, Jingxian,
Chen, Xin,
Beylerli, Ozal,
Sufianov, Albert,
Zhao, Shiguang,
Yang, Guang (2022) supplemented by postoperative chemotherapy. Platinum
drugs are a class of chemotherapeutic
drugs that affect
Background: To examine fundamental characteristics of clinical trials with therapeutic
drugVaiman, E.E.,
Shnayder, N.A.,
Zhuravlev, N.M.,
Petrova, M.M.,
Asadullin, A.R.,
Al-Zamil, M.,
Garganeeva, N.R.,
Shipulin, G.A.,
Cumming, G.,
Nasyrova, R.F. (2022) (LQTS) as a cardiac adverse
drug reaction is a multifactorial symptomatic disorder,
the development
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) and tumor surgery are limited by anticancer
drug resistance and tumor invasion. Evidence suggests
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) and cholinergic. Metabolic disorders are the most severe adverse
drug reactions (ADRs) and lead to cardiovascular
Yanchao, L.,
Sibin, Z.,
Gareev, I.,
Huan, X.,
Junfei, Z.,
Chunyang, L.,
Beylerli, O.,
Sufianov, A.,
Chao, Y.,
Yuyan, G.,
Xun, X.,
Ahmad, A. (2022) patients, to clarify the common genes of both, and to identify common pathways and potential
drugs